Last but not least, after introducing the K47Q and R354Q mutations in the context of optimized chimeras with four nanobodies recognizing HER2, we established the proof of concept that it is possible to specifically redirect the infection of pseudotyped VSV or pseudotyped lentiviruses toward cells expressing this receptor. Here, ERBB2 is linked to infection.